Immunomodulatory effects of VEGF: Clinical implications of VEGF-targeted therapy in human cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)692-696
Number of pages5
JournalCancer Biology and Therapy
Issue number9
Publication statusPublished - May 1 2010


  • Bevacizumab
  • Immune system
  • Infection
  • Sepsis
  • VEGF
  • VEGF-targeted therapy

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Oncology
  • Pharmacology

Cite this